SMOC2 and endometrial carcinoma: Most recently, it was demonstrated that SMOC2 expression in endometrial carcinoma was closely associated with the cancer stem cell (CSC) markers, CE133 and CD44, and the silencing of SMOC2 enhanced chemosensitivity14.